- Report
- July 2023
- 284 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- October 2023
- 84 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Pivampicillin is an antibiotic used to treat a variety of bacterial infections. It belongs to the penicillin class of antibiotics and is a semi-synthetic derivative of ampicillin. Pivampicillin is used to treat infections caused by susceptible Gram-positive and Gram-negative bacteria, including those of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat some sexually transmitted diseases. Pivampicillin is available in both oral and injectable forms.
The market for pivampicillin is driven by the increasing prevalence of bacterial infections, the rising demand for antibiotics, and the growing awareness of the importance of antibiotic stewardship. The market is also driven by the increasing availability of generic versions of the drug, which are more affordable than branded versions.
Some companies in the pivampicillin market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more